M E Hartnett
Overview
Explore the profile of M E Hartnett including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
749
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Raghuveer T, Zackula R, Hartnett M
J Perinatol
. 2024 May;
45(2):282-286.
PMID: 38730278
Until recently, the standard care for retinopathy of prematurity (ROP) was destructive treatment of the peripheral avascular retina, most often using laser therapy. Now, intravitreal anti-vascular endothelial growth factor (anti-VEGF)...
2.
Friddle K, Yoder B, Hartnett M, Henry E, DiGeronimo R
Int J Pediatr
. 2017 Feb;
2017:9372539.
PMID: 28163726
Current American retinopathy of prematurity (ROP) screening guidelines is imprecise for infants ≥ 30 weeks with birth weights between 1500 and 2000 g. Our objective was to evaluate a risk...
3.
Sleath B, Carpenter D, Blalock S, Sayner R, Muir K, Slota C, et al.
Health Educ Res
. 2015 Sep;
30(5):693-705.
PMID: 26338986
Little is known about how ophthalmologist-patient communication over time is associated with glaucoma patient long-term adherence. The purpose of our study was to examine the association between provider use of...
4.
Maile L, Gollahon K, Wai C, Byfield G, Hartnett M, Clemmons D
Diabetologia
. 2011 Dec;
55(3):835-44.
PMID: 22193512
Aims/hypothesis: We have previously shown that the association of integrin-associated protein (IAP) with tyrosine phosphatase non-receptor type substrate-1 (SHPS-1) regulates the response of cells, including osteoclasts, osteoblasts, smooth muscle and...
5.
Wallace D, Freedman S, Hartnett M, Quinn G
Arch Ophthalmol
. 2011 May;
129(5):591-6.
PMID: 21555612
Objectives: To investigate prospectively whether the presence of pre-plus disease predicts progression to severe retinopathy of prematurity (ROP) requiring laser treatment. Methods: Posterior retinal video recordings were obtained during 710...
6.
Sleath B, Blalock S, Robin A, Hartnett M, Covert D, DeVellis B, et al.
Eye (Lond)
. 2009 Aug;
24(4):624-31.
PMID: 19648896
Purpose: The purpose of this study was to develop and evaluate the psychometric properties of (a) a glaucoma medication self-efficacy scale and (b) a glaucoma outcome expectations scale. Patients And...
7.
Penn J, Madan A, Caldwell R, Bartoli M, Caldwell R, Hartnett M
Prog Retin Eye Res
. 2008 Jul;
27(4):331-71.
PMID: 18653375
Collectively, angiogenic ocular conditions represent the leading cause of irreversible vision loss in developed countries. In the US, for example, retinopathy of prematurity, diabetic retinopathy and age-related macular degeneration are...
8.
Hartnett M, Stratton R, Browne R, Rosner B, Lanham R, Armstrong D
Diabetes Care
. 2000 Jun;
23(2):234-40.
PMID: 10868837
Objective: To compare serum markers of oxidative stress with diabetic retinopathy severity Research Design And Methods: This cross-sectional study compared patients with types 1 and 2 diabetes with control subjects...
9.
Beausencourt E, Remky A, Elsner A, Hartnett M, Trempe C
Ophthalmology
. 2000 Feb;
107(2):375-85.
PMID: 10690842
Objective: To perform three-dimensional, noninvasive, quantitative analysis of cystoid macular edema and macular cysts using infrared scanning laser tomography and to correlate findings with visual acuity (VA) as a basis...
10.
Remky A, Beausencourt E, Hartnett M, Trempe C, Arend O, Elsner A
Graefes Arch Clin Exp Ophthalmol
. 1999 Dec;
237(11):897-901.
PMID: 10541899
Background: Cystoid macular edema (CME), a cause of central visual loss, is described in various pathologies. Typically, the fluorescein angiogram confirms the diagnosis and provides qualitative information as to the...